Dental Prosthetics Market Swot Analysis, Major Key Players Revenue, Analysis And Forecasts To 2023

 Overview

The Global Dental Prosthetics Market is expected to register a CAGR of 5.5% and is anticipated to reach USD 5659.4 Million by 2023. Dental prosthetics are mostly in use for the improvement of damaged or deficient teeth. It improves functions as well as the appearance of teeth. It also deals with the permanent or temporary replacement of missing teeth. Dental adhesives or screws are used to fix the dental prosthesis to teeth or dental implant.

The increasing number of dental caries, increasing per capita disposable incomes in emerging markets, rising dental tourism, and growing cosmetic dentistry treatments are the major drivers propelling market growth. However, the cost of dental procedures, the grey market of dental prosthetics, and slow adoption of new technology may hinder the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2905 

Market Dynamics

Dental caries is not only prevalent in children but also adults. About 1.8 million dentists are working around the world, and over 93% of WHO member states report having less than one dentist per 1000 population. 60%-90% of the children are facing dental problems, and the majority are from developed countries. Due to changing eating habits and increasing consumption of junk food and sugar are leading to an increase in several dental patients. Additionally, rising per capita disposable incomes in emerging markets, rising dental tourism, and increasing cosmetic dentistry treatments are driving the market growth. On the other hand, the cost of dental procedures, the grey market of dental prosthetics, and slow adoption of new technology are anticipated to hamper the market growth.

Segmentation

The global dental prosthetics market has been segmented into type, diagnosis & treatment, and end user. By type, the market has been divided into denture, crown, bridges, veneer, abutment, and inlays. The global dental prosthetics market, by type of material, has been segregated into porcelain-fused-to-metal (PFM), metal, all-ceramic, and others. By end user, the market has been divided into hospitals and clinics and dental research laboratories. The hospitals and clinics segment accounted for a market value of USD 3133.8 million in 2016.  

Key Players

The prominent players in the global dental prosthetics market are Henry Schein, Inc. (US), DENTSPLY Sirona (US), 3M (US), Institut Straumann AG (Switzerland), Zimmer Biomet (US), Nobel Biocare (Switzerland), Ivoclar Vivadent AG (Liechtenstein), Osstem Implant (South Korea), Planmeca OY (Finland), and CAMLOG Biotechnologies AG (Switzerland).

Some of the key strategies followed by the players operating in the global dental prosthetics market were innovation, product development, acquisition, and expansion.

Regional Analysis

The global dental prosthetics market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is estimated to dominate the global dental prosthetics market during the forecast period. This is attributed to increasing incidences of periodontal diseases and the rising consumption of junk foods. The European market for dental prosthetics is expected to be the second-largest during the forecast period. The increasing geriatric population, which is a crucial target demographic, is expected to boost the growth of the market in this region.     

Asia-Pacific is estimated to be the fastest-growing market due to rising healthcare spending by governments across developing countries and medical tourism. Moreover, a large pool of the patient population, untapped markets, and favorable government policies are likely to provide good opportunities for market players in this region. Moreover, in the Asia-Pacific region, Australia accounted for a market share of 26.8% in 2016. Furthermore, the market in the Middle East & Africa is expected to witness steady growth due to limited access and healthcare affordability among the developing population.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/human-growth-hormone-market-6494 

Global Growth hormone Market Set For Big Growth - Foresight By 2023

 Market Research Future (MRFR’s) latest study reveals that the global market for human growth hormone will surge at an impressive CAGR of 7.50% during the review period (2018-2023). Growth hormone deficiency falls under the list of endocrine conditions. Growth hormone deficiency is prevalent across the globe and the reasons for the condition usually vary from person to person. Though the condition is rare, its prevalence rate has increased to a noteworthy level in recent times. In many cases, brain injury has been identified as a primary cause of growth hormones deficiency. Low level of growth hormone secretion can lead to altered body composition, osteoporosis, insulin resistance, lipid abnormalities, reduced energy levels, and reduced muscle strength. Low growth hormone secretion is usually an issue that starts at a young age and if not addressed promptly, may have major implications in later stages of life.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6494 

Today, the level of awareness about the condition is much higher than in the past. Modern parents show higher vigilance in monitoring their offspring’s overall physical development and are quick to react to any anomaly they observe. Increasing awareness about endocrine disorders is reflecting favourably on the global human growth hormone market. Demand for growth hormones has increased substantially. Moreover, arrival of more effective hormones has had a positive impact on the popularity of such medical products.

Global Human Growth Hormone Market: Segmental Analysis

MRFR’s report offers a thorough segmental analysis of the market on the basis of brand, route of administration, application, and distribution channel. By brand, the market has been segmented into norditropin, genotropin, mumatrope, sainzen, omnitrope and others. Among these, the norditropin segment is holds the dominant share of the market and is expected retain its positing over 2023. In 2017, the segment stood at USD 1494.98 Mn and is projected to witness a double-digit CAGR during the forecast period. By application, the market has been segmented into growth hormone deficiency, idiopathic short stature, small for gestational age, turner syndrome,

prader-willi syndrome and others. The growth hormone deficiency segment accounts for the largest share of the market and is expected to exhibit a CAGR of 7.07% during the assessment period. By route of administration, the market has been segmented into subcutaneous, intramuscular, intravenous and oral. The subcutaneous segment currently holds the leading position and accounted for more than two-third share of the market in 2017. The segment is expected to remain highly attractive throughout the assessment period. By distribution channel, the market is segmented into hospital pharmacies, clinics, retail pharmacies and e-commerce websites. The hospital pharmacies segment represented close to 40% market share in 2017 and is project to witness a health growth over the next couple of years.

Global Human Growth Hormone Market: Regional Analysis

The report covers the human growth hormone market across Americas, Asia Pacific (APAC), Europe, the Middle East & Africa. The market is Americas is expected to remain highly lucrative during the review period. In 2017, Americas commanded over 49.18% share of the market and is expected to maintain its dominant position in 2018 and beyond. Factors such as the increasing prevalence of growth hormone deficiency, high healthcare spending, and widespread awareness among consumers are partly driving the growth of the market in the region. Americas is followed by Europe and APAC respectively. Sales of human growth hormones have also picked up pace in GCC countries, which brings MEA under the radar of market players operating on a global level.

Global Human Growth Hormone Market: Competitive Landscape

Some of leading market players profiled in the report include Pfizer Inc., Novo Nordisk A/S, Anhui Anke Biotechnology Co. Ltd., Eli Lilly and Company, GeneScience Pharmaceuticals Co. Ltd., Genetech Inc., Novartis AG, Biopartners GmbH, Zhongshan Hygene Biopharm Co. Ltd., Merck KGaA, Ipsen S.A. and Lifetech Labs

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/human-growth-hormone-market-6494 

Global Dental Restorative and Regenerative Market Set For Big Growth - Foresight By 2023

 Market Research Future published a Cooked research report on “Global Dental Restorative and Regenerative Material Market Research Report - Forecast till 2023”  – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

3M (U.S.), Biotech Dental (Europe), botiss biomaterials GmbH (Europe), Dentsply Sirona. (U.S.), Henry Schein, Inc. (U.S.), Institut Straumann AG (Europe), KaVo Kerr (U.S.), Keystone Dental, Inc. (U.S.), Zimmer Biomet (U.S.) are some of the leading players at the cutting edge of the competition in the market of Dental Restorative and Regenerative Material, globally.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4332 

Overview

The Global Dental Restorative and the Regenerative Material Market are expected to register a CAGR of 6.7% and is anticipated to reach USD 2679.7 Million by 2023. 

Dental restorative and regenerative materials are used to replace damaged or lost teeth, mostly it happens due to dental caries or dental cavities. Simultaneously, dental restorative and regenerative materials are also used in cosmetic dentistry, which improves the appearance of the teeth and enhances the smile of an individual.

The increasing prevalence of dental disorders, availability of identical material, growing dental tourism, rising adherence and biocompatibility, and increasing disposable income are responsible for propelling the market growth. However, the high cost of dental restorative and regenerative material and lack of awareness about dental procedures are hampering the growth of the market.

Market Dynamics

The rise in the cases of dental complications is expected to drive the growth of the market. According to the World Dental Federation, more than 3.9 billion people are affected by oral diseases, and about half of the world’s population is suffering from untreated tooth decay. Moreover, increasing dental tourism is also likely to support market growth. On the other hand, the high cost of dental materials and lack of awareness is anticipated to hamper the market growth.

Global Dental Restorative and Regenerative Material Market Size, by End User, 2016 (USD Million)

Segmentation

The global dental restorative and the regenerative material market has been segmented into type and end user. By type, the market has been segmented into restorative material and regenerative material. Restorative material segment has been divided into an amalgam, resin-base composite, glass ionomer, resin-modified glass ionomer, porcelain, metal, porcelain-fused-to-metal. The regenerative material segment is further segmented into bone graft materials, membranes, and tissue regeneration products.  

Based on end user, the market has been segmented into dental research laboratories and dental hospitals and clinics. The dental hospitals and clinics segment accounted for a market share of 82.30% in 2016.

Key Players

The prominent players in the global dental restorative and regenerative material market are DENTSPLY Sirona, Henry Schein, Inc., Kerr Corporation, Keystone Dental, Inc., Nobel Biocare Services AG, 3M, Biotech Dental, botiss biomaterials GmbH, Institut Straumann AG, and Zimmer Biomet.

Some of the key strategies followed by the players operating in the global dental restorative and regenerative material market were innovation, product development, acquisition, and expansion.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/dental-regenerative-material-market-4332 

Malocclusion Market Professional Overview 2020-2023 With Major Vendors Size, Shares And Worldwide Demand

 

Market Highlights

Malocclusion is the misalignment of teeth. Malocclusion is most often hereditary, but it can also occur due to other reasons i.e. childhood habits such as thumb sucking, pacifier use beyond age 3, and others, extra teeth or lost teeth, ill-fitting dental fillings, and jaw tumors. There are three major classes of malocclusion i.e. Class 1, Class 2, and Class 3.

Increasing prevalence of malocclusion, favorable reimbursement scenario, and rising trend of cosmetic dentistry are the key factors driving the malocclusion market.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/5094 

However, lack of technological awareness and complications associated with malocclusion treatment may hinder the growth of the market to an extent. The lack of technological awareness is mainly attributed to the slow adoption rate of new technology by the dentists.

The global malocclusion market is expected to grow at a CAGR of 7.0% during the forecast period, 2017-2023.

Taste the market data and market information presented through more than 296 market data tables and figures spread over 251 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “malocclusion market research report–Global forecast till 2023.”

Key Players in the Malocclusion Market

Some of key the players in the malocclusion market are 3M, A-dec Inc., Adenta GmbH, Align Technology, Inc, American Orthodontics, Biolase, Inc., Carestream Health, Inc., Danaher, DENTAURUM GmbH & Co. KG, Dentsply Sirona, G&H Orthodontics, Henry Schein, Inc., Midmark Corp., Patterson Companies, Inc., Planmeca OY, Rocky Mountain Orthodontics, Septodont Holding, TP Orthodontics, Inc, Ultradent Products Inc., Zimmer Dental Inc., and others.

Regional Analysis

The Americas dominate the malocclusion market owing to the improvement in reimbursement scenario, high healthcare expenditure, and the presence of the leading players in the region. According to the American Dental Association, in the United States, Maryland, Utah, Arkansas, and Massachusetts have the highest Medicaid FFS reimbursement rates i.e. 79.3%, 75.3%, 75.2%, and 74.1% respectively, whereas, Wisconsin, California, Washington, Maine, and Iowa have the lowest coverage relative to private dental insurance reimbursement rates.

Europe holds the second position in the malocclusion market. It is expected that the support provided by the government bodies for research & development, increasing healthcare expenditure, and rising prevalence of malocclusion are propelling the growth of the malocclusion market in the European region. According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014 i.e. EUR 321 billion which is further followed by France with EUR 237 billion and then United Kingdom with EUR 223 billion.

Asia Pacific region is projected to be the fastest growing region during the forecast period. Rapidly improving technology and the presence of huge patient pool drive the growth of this market in Asia Pacific region.

The Middle East and Africa hold the least share of the malocclusion market owing to the presence of poor and slow developing countries, especially, in the African region.

Segmentation

The global malocclusion market is segmented on the basis of class, treatment, and end user.

On the basis of the class, the market is classified into class I, class II, and class III.

On the basis of the treatment, the market is segmented into orthodontic braces, surgery, and others. The orthodontic braces segment is further sub-segmented into metal braces, ceramic braces, clear aligner, and others.

On the basis of the end -users, the market is segmented into the hospital and clinics, dental clinics, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/malocclusion-market-5094 

Global Dental Implants Market Set For Big Growth - Foresight By 2023

 Global Dental Implants Market is expected to register a CAGR of 4.6%and is anticipated to reach USD 6229.8 million by 2023.

Dental implant is the option for those people who have lost their tooth or teeth, owing to an injury, periodontal disease or some other reasons. It is an artificial tooth root that allow dentist to mount the replacement of teeth, by placing it into the jaw.  The dental implant is a metal post made up of titanium which help in surgeries beneath the gums. According to a report published by the Centers for Disease Control and Prevention, in 2015, around 84.7% of children aged 2-17 years, have visited dentist for checkup, and more than 62.7% of adults aged above 65 years have visited  dentist for dental implants.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/2753 

Global Dental implants Market – Overview

The global dental implants market is rising with a swift phase; mainly owing to increase in patient population. According to the World Health Organization (WHO), in 2014, around 30% of the older aged (65-74) population globally have lost their natural teeth, around 60-90% of the school children globally and nearly 100% of the adults were believed to have dental cavities, about 15-20% middle aged (35-44 years) adults have found to have severe periodontal disease. Increasing consumer awareness about technology associated with oral health and rapidly increasing population globally leads to the growth of the dental implant market. Dentistry as a branch of healthcare has also further expanded and developed in its sub branches resulting in specialist oral care depending upon the type of treatment required for the oral care. Major specializations are orthodontics, endodontics, prosthodontics, and periodontics

Companies are continuously inventing in new products to capture the market globally. Thus, major players invest more in research and development activities, in order to lead the global market. In this regards, Osstem Implant, in 2015, invested in research and development to push for invention in the field of dental implants and persistently develops state-of-the-art products and thus, becoming the leader and the ‘First Mover’ in global dental implant market. Osstem Implant is also focusing on the expansion of sales network globally, advancement in education programs, and strategies for marketing.

In 2016, Zimmer Biomet dental division has introduce new technology of dental implants, and there surgical and restorative components. The company introduce 3.1-mmD Eztetic implant, which add-on improvement on existing available implants. According to the company, this product achieved a 43% higher fatigue strength in comparison to selected competitive implants of similar technical features. Increasing in genetic population globally and consumption of tobacco are the factors that leads the market of dental implants. Moreover companies are more focus to capture the market.

Competitive Analysis

Institut Straumann AG (Switzerland), 3M (U.S.), Osstem Implant (South Korea), Nobel Biocare (Part of Danaher corporation (U.S.), Dentsply Sirona (U.S.), Zimmer Biomet (U.S.), CAMLOG Biotechnologies AG (Switzerland), Neobiotech Inc. (U.S.) are some of the leading players at the cutting edge of the competition in the market of dental implants, globally.

Global Dental Implants Market   - Regional Analysis

The market of dental implants is much higher in the Americas region. There are huge population which are missing all their teeth in one or both jaws. According to a report published in 2014, by the National Institute of Dental and Craniofacial Research, government initiated the National Oral Health Plan to improve the quality of life of the Americans. Through this program they were focusing on change in public perceptions, change in policymakers' perceptions, and change in health providers' perceptions.

Europe is also considered a huge market for dental implants players, owing to presence of huge population affected with oral diseases. Governments are more focusing on educating their public in order to minimize the patient’s population by educating them about the relationship between mouth and rest of the body.

Asia Pacific and the Middle East and Africa region are considered untapped markets. Whereas, country like India and China of Asia Pacific region are considered as the fastest growing region due to presence of huge population suffering with oral health issues. Japan is well developed country and have well established healthcare system and technology, whereas developing countries are still focusing on new drugs and technology for the treatment of dental implants, this gap between the developed and developing countries will present significant growth opportunity for the dental implants market players in the coming years. Additionally, they are open to adopt new technology and best treatment option from developed countries in order to improve the quality of life for their public. Whereas, the Middle East and Africa are low growth market due to lack of investment.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/dental-implants-market-2753 

Global AR & VR in Healthcare Market Set For Big Growth - Foresight By 2023

 

Market Highlights

The AR & VR in healthcare market is expected to grow at an approximate CAGR of 30.2% during forecast period, 2018–2023.

Rising demand to reduce healthcare cost is one of the key factors driving the AR & VR in healthcare market. For instance, with the use of AR navigation system nearly USD 288 million can be saved on minimally-invasive surgical procedures in the US.

Various other factors such as rising government funding, high prevalence of chronic diseases, rising adoption of AR and VR in fitness management, increasing penetration of connected devices in the healthcare sector, and rising awareness about VR therapy are also expected to propel the growth of the market.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7208 

However, concerns regarding data privacy, lack of expertise among medical practitioners, and lack of competence in deployment of the AR and VR solutions can hinder the market growth over the forecast period.

Segmentation

The AR & VR in healthcare market is segmented based on technology, offering, device type, application, end user, and region.

The global market for AR & VR in healthcare, by technology is segmented into AR technology and VR technology. The AR technology segment is further classified as marker-based AR and markerless AR. The marker-based AR segment includes passive marker, and active marker. The markerless AR segment includes model-based tracking, and image processing-based tracking. The VR technology segment is further classified as nonimmersive technology, and semi-immersive and fully immersive technologies.

Based on offering, the market is segmented into hardware components and software. The hardware components segment is further classified as sensors, semiconductor component, displays and projectors, position tracker, cameras, and others. The sensors segment includes accelerometer, gyroscope, magnetometer, and proximity sensor. The semiconductor component segment includes controller/processor, and integrated circuits. The software segment is further classified as software development kits, and cloud-based services.

Based on device type, the market is segmented into AR device type, and VR device type. The AR device type segment is further classified as head-mounted display, and handheld device. The VR device type segment is further classified as head-mounted display, gesture-tracking device, and projectors and display walls. The gesture-tracking device segment includes data gloves, and others.

Based on application, the market is segmented into fitness management, patient care management, surgery, pharmacy management, medical training and education, and others.

Based on end user, the market is segmented into hospitals & clinics, surgical centres, pharmaceutical companies, research and academic institutes, and others.

Regional Analysis

The Americas dominated the global market for AR & VR in healthcare owing to the rising demand to reduce healthcare cost and presence of major market players.

In 2017, it was estimated that Europe stood second in the AR & VR in healthcare market. This can be attributed to the rising funding for innovation and increasing technological advancements. For instance, the European Union’s Horizon 2020 programme is allocating nearly USD 91.51 billion of funding over seven years for research and innovation.

Asia Pacific was projected to be the fastest growing region in 2017. Increasing healthcare expenditure and high prevalence of chronic diseases drives the regional markets of the Asia Pacific region.

On the other hand, the Middle East and Africa held least share in the AR & VR in healthcare market due to the low per capita income and stringent government policies, especially within the African region.

Key Players

Some of the key players in the AR & VR in healthcare market are Atheer, Augmedix, Daqri, Firsthand Technology, Google, Medical Realities, Microsoft, Mindmaze, Oculus VR, Psious, EchoPixel, Inc., Osso VR Inc., SURGICAL THEATER, LLC, Orca Health, Inc., Hologic Inc., 3D Systems, Inc., and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/ar-vr-in-healthcare-market-7208 

China IUCD Market Professional Overview 2020-2023 With Major Vendors Size, Shares And Worldwide Demand

 Market Scenario:

IUCD stands for Intra-Uterine Contraceptive Devices. It is a device inserted into the uterus to prevent pregnancy. The device is T-shaped made up of flexible plastic with a coating of thin copper wire. China, ICUD was the most important tool to limit the couples to have one child. One child policy of China was introduced in 1979 favored the growth of this market till 2015. But in January 2016, a new law named “Two-child policy” become effective, which was passed by standing committee of National People’s Congress in December 2016. According to census 2010, the population change in is 7.39 per year. The market for IUCD is showing a steady rise in China because most of the women still do not want to have a second child even after the passage of second child policy. China IUCD market is expected to reach USD 20 billion in 2023 from USD 14 billion in 2016 with a CAGR of approximately 8.72% during the forecast period 2017-2023.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/1306 

Study objectives:

• Main objective of this research is to provide information about IUCD market, types of provider services and payer services.
• To provide detailed analysis of the market structure along with forecast for the next seven years of the various segments and sub-segments of the IUCD market.
• To provide insights about factors affecting the market growth.
• To analyze the IUCD based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to China
• To provide country level analysis of the market with respect to the current market size and future prospective.
• To provide country level analysis of the market for segments by diagnosis and by end users and its sub-segments.
• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the China IUCD market. 

Key Players
SMB Corporation Of India, Bayer HealthCare Pharmaceuticals Inc. (US), Mona Lisa (Belgium), Teva Women’s Health, DKT International (US).

Segmentation:
The market for IUCD in China is segmented into types which include hormonal IUD, copper IUD and other types. The end users are hospitals, Clinics and others.

Regional Analysis:
On the basis of regions market for IUCD in China is segmented into North China, Northeast China, East China, South Central China, Southwest China and Northwest China. East China account for the largest market share. It has the highest population and largest population density. The market in China is showing steady growth due to an increase in the population in all the regions.

Intended Audience

• Healthcare IT companies
• Healthcare companies
• Contract Research Organizations (CROs)
• Research and Development (R&D) Companies
• Academic Medical Institutes and Universities

The report for IUCD of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/china-iucd-market-1306